• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人钠/碘同向转运体在肿瘤细胞系中的功能活性

Functional activity of human sodium/iodide symporter in tumor cell lines.

作者信息

Petrich T, Knapp W H, Pötter E

机构信息

Department of Nuclear Medicine, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30625 Hannover, Germany.

出版信息

Nuklearmedizin. 2003 Feb;42(1):15-8.

PMID:12601449
Abstract

AIM

The sodium/iodide symporter (NIS) actively transports iodide into thyrocytes. Thus, NIS represents a key protein for diagnosis and radioiodine therapy of differentiated thyroid cancer. Additionally, in the future the NIS gene may be used for cancer gene therapy of non-thyroid-derived malignancies. In this study we evaluated the functionality of NIS with respect to iodide uptake in a panel of tumor cell lines and compared this to gene transfer efficiency.

METHODS

A human NIS-containing expression vector and reporter-gene vectors encoding beta-Galactosidase- or EGFP were used for transient transfection of 13 tumor cell lines. Following transfection measurements of NIS-mediated radioiodide uptake using Na(125)I and of transfection efficiency were performed. The latter included beta-Galactosidase activity measurements using a commercial kit and observation by fluorescence microscopy for EGFP expression.

RESULTS

In contrast to respective parental cells, most NIS-transfected cell lines displayed high, perchlorate-sensitive radioiodide uptake. Differences in radioiodide uptake between cell lines apparently corresponded to transfection efficiencies, as judged from reporter-gene assays.

CONCLUSION

With respect to iodide uptake we provide evidence that NIS is functional in different cellular context. As iodide uptake capacity appears to be well correlated to gene transfer efficiency, cell type-specific actions on NIS (e. g. post-translational modification such as glycosylation) are not inhibitory to NIS function. Our data support the promising role of NIS in cancer gene therapy strategies.

摘要

目的

钠/碘同向转运体(NIS)可将碘主动转运至甲状腺细胞内。因此,NIS是分化型甲状腺癌诊断及放射性碘治疗的关键蛋白。此外,未来NIS基因可能用于非甲状腺来源恶性肿瘤的癌症基因治疗。在本研究中,我们评估了一组肿瘤细胞系中NIS在碘摄取方面的功能,并将其与基因转染效率进行比较。

方法

使用含人NIS的表达载体以及编码β-半乳糖苷酶或增强型绿色荧光蛋白(EGFP)的报告基因载体,对13种肿瘤细胞系进行瞬时转染。转染后,使用Na(125)I测量NIS介导的放射性碘摄取,并检测转染效率。后者包括使用商用试剂盒测量β-半乳糖苷酶活性,以及通过荧光显微镜观察EGFP表达。

结果

与各自的亲本细胞相比,大多数转染NIS的细胞系表现出高的、对高氯酸盐敏感的放射性碘摄取。根据报告基因检测判断,细胞系之间放射性碘摄取的差异显然与转染效率相对应。

结论

关于碘摄取,我们提供证据表明NIS在不同细胞环境中具有功能。由于碘摄取能力似乎与基因转染效率密切相关,对NIS的细胞类型特异性作用(例如翻译后修饰如糖基化)不会抑制NIS功能。我们的数据支持NIS在癌症基因治疗策略中的潜在作用。

相似文献

1
Functional activity of human sodium/iodide symporter in tumor cell lines.人钠/碘同向转运体在肿瘤细胞系中的功能活性
Nuklearmedizin. 2003 Feb;42(1):15-8.
2
Establishment of radioactive astatine and iodine uptake in cancer cell lines expressing the human sodium/iodide symporter.在表达人钠/碘同向转运体的癌细胞系中建立放射性砹和碘摄取。
Eur J Nucl Med Mol Imaging. 2002 Jul;29(7):842-54. doi: 10.1007/s00259-002-0784-7. Epub 2002 Apr 11.
3
Ectopic expression of the thyroperoxidase gene augments radioiodide uptake and retention mediated by the sodium iodide symporter in non-small cell lung cancer.甲状腺过氧化物酶基因的异位表达增强了非小细胞肺癌中由钠碘同向转运体介导的放射性碘摄取和潴留。
Cancer Gene Ther. 2001 Aug;8(8):612-8. doi: 10.1038/sj.cgt.7700354.
4
Sodium/iodide symporter gene transfection increases radionuclide uptake in human cisplatin-resistant lung cancer cells.钠/碘同向转运体基因转染增加人顺铂耐药肺癌细胞中的放射性核素摄取。
Clin Transl Oncol. 2015 Oct;17(10):795-802. doi: 10.1007/s12094-015-1307-x. Epub 2015 Jun 27.
5
A transporter gene (sodium iodide symporter) for dual purposes in gene therapy: imaging and therapy.一种用于基因治疗双重目的的转运体基因(碘化钠同向转运体):成像与治疗。
Curr Gene Ther. 2002 Dec;2(4):393-402. doi: 10.2174/1566523023347599.
6
Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines.前列腺特异性抗原(PSA)启动子驱动的碘化钠同向转运体在前列腺癌细胞系中的雄激素诱导表达。
Cancer Res. 1999 May 1;59(9):2136-41.
7
Cotransfected sodium iodide symporter and human tyroperoxidase genes following human telomerase reverse transcriptase promoter for targeted radioiodine therapy of malignant glioma cells.转染人端粒酶逆转录酶启动子的钠碘同向转运体和人甲状腺过氧化物酶基因用于恶性神经胶质瘤细胞的靶向放射性碘治疗。
Cancer Biother Radiopharm. 2011 Aug;26(4):443-51. doi: 10.1089/cbr.2010.0908. Epub 2011 Jul 28.
8
Sodium iodide symporter: its role in nuclear medicine.碘化钠同向转运体:其在核医学中的作用。
J Nucl Med. 2002 Sep;43(9):1188-200.
9
Probasin promoter (ARR(2)PB)-driven, prostate-specific expression of the human sodium iodide symporter (h-NIS) for targeted radioiodine therapy of prostate cancer.前列腺素启动子(ARR(2)PB)驱动的人钠碘同向转运体(h-NIS)在前列腺中的特异性表达,用于前列腺癌的靶向放射性碘治疗。
Cancer Res. 2003 Nov 15;63(22):7840-4.
10
Adenovirus-mediated transfer of the thyroid sodium/iodide symporter gene into tumors for a targeted radiotherapy.腺病毒介导的甲状腺钠/碘同向转运体基因转移至肿瘤用于靶向放射治疗。
Cancer Res. 2000 Jul 1;60(13):3484-92.